| ENZON PHARMACEUTICALS, INC. |
10%+ Owner |
Common Stock, $0.01 par value |
4.72M |
$665K |
$0.14 |
Aug 13, 2021 |
By Jonathan Couchman |
| ENZO BIOCHEM INC |
Director |
Common Stock |
0 |
$324K |
$1.17 |
Aug 20, 2025 |
In retirement accounts |
| ENZON PHARMACEUTICALS, INC. |
10%+ Owner |
Common Stock, $0.01 par value |
2.04M |
$288K |
$0.14 |
Aug 13, 2021 |
By Xstelos Corp. |
| ENZO BIOCHEM INC |
Director |
Common Stock |
0 |
$167K |
$1.17 |
Aug 20, 2025 |
Direct |
| ENZO BIOCHEM INC |
Director |
Common Stock |
0 |
$152K |
$1.17 |
Aug 20, 2025 |
By Xstelos Holdings, Inc. |
| ENZON PHARMACEUTICALS, INC. |
10%+ Owner |
Common Stock, $0.01 par value |
633K |
$89.3K |
$0.14 |
Aug 13, 2021 |
By Myrexis, Inc. |
| ENZON PHARMACEUTICALS, INC. |
10%+ Owner |
Common Stock, $0.01 par value |
350K |
$49.4K |
$0.14 |
Aug 13, 2021 |
By Couchman Family Fund |
| ENZO BIOCHEM INC |
Director |
Common Stock |
0 |
|
|
Aug 20, 2025 |
By Couchman Family Fund |
| ENZO BIOCHEM INC |
Director |
Common Stock |
0 |
|
|
Aug 20, 2025 |
By Myrexis, Inc. |